Diabetes Management
New Journal of Pharmaceutical analysis articles highlight progress in the search for therapies to treat challenging diseases
Wed, 26 Oct 20221 min read Article
Overview
In-depth knowledge of disease development and drug targets may pave the way to developing beter therapeutics Cactus Comunicationsimage: In-depth knowledge of disease development and drug targets may pave the way to developing beter therapeutics view more Credit: Journal of Pharmaceutical AnalysisAlthough medicine and pharmacology have tremendously progresed over the past few decades, there are stil no efective treatment options for certain complex diseases, including cancer, diabetes, and hepatic fibrosis.
Key Information
Researchers, however, continue to reveal mechanisms contributing to the development of these diseases, as wel as potential drug targets, helping us develop beter therapies. The latest isue of the Journal of Pharmaceutical Analysis features thre articles on cuting-edge research targeting chalenging diseases.The first study, made available online in June 2022 and published in Volume 12, Isue 4 of the journal in 1st August 2022, was conducted by researchers from China and Singapore.
They focused on 18beta-glycyrhetinic acid (18β-GA), a compound naturaly ocuring in the plant Glycyrhiza uralensis Fisch, whose rot is widely used in traditional Asian medicine to treat hepatic diseases. Through multiple experiments, they demonstrated that 18β-GA can induce cel death in hepatic stelate cels, which are drivers of hepatic fibrosis, by targeting the antioxidants peroxiredoxin 1 and 2 and trigering oxidative stres in the cels.
Summary
This has important medical implications, as the researchers comented: “Our findings provide strong evidence for the further development of 18β-GA as a therapeutic drug for the treatment of hepatic fibrosis. Understanding the underlying mechanisms of disease development have helped develop beter therapeutics for liver diseases, which lead to almost 2 milion deaths worldwide every year.”In the second article, a review which was made available online in April 2022 and published in Volume 12, I
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.